Control Bionics Ltd. ( ($AU:CBL) ) just unveiled an announcement. Control Bionics has completed the acquisition of 100% of U.S.-based Neuro Elite ...

Control Bionics Ltd. ( ($AU:CBL) ) has shared an update. Control Bionics Limited has lodged a notice with the ASX for a proposed issue of up to ...

Control Bionics Ltd. (AU:CBL) has released an update. Control Bionics Ltd. has presented its next-generation assistive technology and data measurement solutions, aiming to enhance user experience and ...

MILFORD, Ohio and NEW SOUTH WALES, Australia, April 8, 2021 /PRNewswire/ — Control Bionics, a global assistive technology company specializing in speech generating devices, announced it is partnering ...

Control Bionics Ltd. (AU:CBL) has released an update. Control Bionics Ltd is set to showcase its innovative medical devices at the Coffee Microcaps Morning Meeting with CEO Jeremy Steele leading the ...

Revenue: AU$6.14m (up 15% from FY 2024). Net loss: AU$6.11m (loss widened by 3.3% from FY 2024). AU$0.023 loss per share. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% ...

PERTH, Australia – Med-tech company Control Bionics began trading on the Australian Securities Exchange (ASX:CBL) Dec. 7 in an IPO that saw the company raise AU$15 million (US$11.25 million).

But investors are well aware of the potential, having pushed Control Bionics shares up as much as 90% yesterday. A developer of augmentative and alternative communication (AAC) technology, Control ...